Innophos Holdings, Inc. 4

4 · Innophos Holdings, Inc. · Filed Apr 17, 2015

Form 4

Period: 2015-04-15

DirectorCEO

Transactions

Exercise/Conversion
Option To Purchase Common Stock
2015-04-15−29,808→ 19,192 total
Exercise: $18.38Exp: 2018-04-25→ Common Stock (29,808 underlying)
Exercise/Conversion
Common Stock
2015-04-15$15.20/sh+193$2,934→ 208,793 total
Tax Payment
Option To Purchase Common Stock
2015-04-15$58.76/sh−13,567$797,197→ 5,625 total
Exercise: $18.38Exp: 2018-04-25→ Common Stock (13,567 underlying)
Sale
Common Stock
2015-04-15$58.68/sh−20,000$1,173,600→ 208,600 total
Exercise/Conversion
Common Stock
2015-04-15$18.38/sh+29,808$547,871→ 238,601 total
Exercise/Conversion
Option To Purchase Common Stock
2015-04-15−193→ 67 total
Exercise: $15.20Exp: 2017-10-21→ Common Stock (193 underlying)
Tax Payment
Option To Purchase Common Stock
2015-04-15$58.76/sh−67$3,937→ 0 total
Exercise: $15.20Exp: 2017-10-21→ Common Stock (67 underlying)

Footnotes (5)

[F1]Transaction(s) carried out by the reporting person pursuant to a plan established on June 13, 2014 under Rule 10b5-1 for the purpose, among others, of diversifying his investment portfolio, exercising options and paying taxes.
[F2]Shares of Common Stock were sold at a price ranging from a low of $58.38 per share to a high of $59.40.
[F3]The reporting person was granted 59,000 options on October 22, 2007, which options vested in three equal annual installments beginning on October 22, 2008.
[F4]The reporting person was granted 49,000 options on April 25, 2008, which options vest in three equal annual installments beginning on April 25, 2009.
[F5]Shares surrendered to issuer in connection with cashless exercise of options.

Documents

1 file